February 11, 2026 11:30 Non Regulatory Flerie’s portfolio company Microbiotica reports positive Phase 1b data for MB310 in patients with ulcerative colitis Read news release
February 2, 2026 09:15 Non Regulatory Flerie’s portfolio company Nanologica acquires Syntagon Read news release
January 20, 2026 Flerie’s portfolio company Chromafora acquires Montrose Environmental Group Denmark Read news release
January 9, 2026 Flerie’s portfolio company KAHR Bio presents strong survival data from Phase II trial with DSP107 and secures USD 22 million in equity funding Read news release
November 4, 2025 Flerie’s portfolio company Empros Pharma reports study results positioning EMP16 as a promising oral weight-loss maintenance therapy Read news release